Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADUCANUMAB: 118 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
118
Total FAERS Reports
2 (1.7%)
Deaths Reported
49
Hospitalizations
118
As Primary/Secondary Suspect
3
Life-Threatening

First Report: 20130118 · Latest Report: 20231128

What Are the Most Common ADUCANUMAB Side Effects?

#1 Most Reported
Amyloid related imaging abnormality-oedema/effusion
53 reports (44.9%)
#2 Most Reported
Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits
40 reports (33.9%)
#3 Most Reported
Superficial siderosis of central nervous system
10 reports (8.5%)

All ADUCANUMAB Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Amyloid related imaging abnormality-oedema/effusion 53 44.9% 1 10
Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits 40 33.9% 0 4
Superficial siderosis of central nervous system 10 8.5% 0 1
Headache 8 6.8% 0 1
Seizure 7 5.9% 0 7

Who Reports ADUCANUMAB Side Effects? Age & Gender Data

Gender: 49.6% female, 50.4% male. Average age: 73.9 years. Most reports from: US. View detailed demographics →

Is ADUCANUMAB Getting Safer? Reports by Year

YearReportsDeathsHosp.
2013 2 0 1
2014 1 0 1
2015 12 1 12
2016 6 0 5
2017 1 0 1
2018 7 0 6
2019 6 0 5
2020 2 0 2
2021 7 1 6
2022 15 0 6
2023 59 0 4

View full timeline →

What Is ADUCANUMAB Used For?

IndicationReports
Dementia alzheimer's type 116

ADUCANUMAB vs Alternatives: Which Is Safer?

ADUCANUMAB vs ADUCANUMAB-AVWA ADUCANUMAB vs ADVAIR ADUCANUMAB vs ADVAIR HFA ADUCANUMAB vs ADVIL ADUCANUMAB vs AFATINIB ADUCANUMAB vs AFINITOR ADUCANUMAB vs AFLIBERCEPT ADUCANUMAB vs AGALSIDASE ALFA ADUCANUMAB vs AGALSIDASE BETA ADUCANUMAB vs AGOMELATINE

Official FDA Label for ADUCANUMAB

Official prescribing information from the FDA-approved drug label.